id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-006824-btcdjmfp	nan	Key Note and State of the Art Lectures	2002-09-07		.txt	text/plain	7577	377	34	In a prospective phase II trial, we treated 37 patients with high dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission [6] . A comparison with similar autologous HCT recipients with NHL who had not been treated with the monoclonal antibody after transplantation indicates that Figure 1 : Overall survival, event-free survival and relapse following autologous bone marrow transplantation in 37 patients with follicular lymphoma during their first complete or first partial chemotherapy-induced remissions this new post-transplant therapy has contributed positively to the treatment outcome. In 1986, a first group of 17 patients (14 with NHL and three with Hodgkin's disease) was described indicating that extended disease-free long-term survival can be attained with high dose therapy followed by allogeneic transplantation utilizing hematopoietic cells obtained either from fully or closely matched related donors [9] .	./cache/cord-006824-btcdjmfp.txt	./txt/cord-006824-btcdjmfp.txt